{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:06:46Z","timestamp":1782403606721,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtos.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T19:14:00Z","timestamp":1626981240000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Dry eye disease flares: A rapid evidence assessment"],"prefix":"10.1016","volume":"22","author":[{"given":"Christopher E.","family":"Starr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-5100","authenticated-orcid":false,"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-351X","authenticated-orcid":false,"given":"Steven","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-6069","authenticated-orcid":false,"given":"Desiree","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Brazzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older","volume":"182","author":"Farrand","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","article-title":"Inflammatory response in dry eye","volume":"59","author":"Yamaguchi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.07.001_bib7","article-title":"Should we reconsider the classification of patients with dry eye disease? [published online November 12, 2019]","author":"Rolando","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"108294","DOI":"10.1016\/j.exer.2020.108294","article-title":"Inflammatory basis for dry eye disease flares","volume":"201","author":"Perez","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jtos.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtos.2018.01.002","article-title":"Web-based longitudinal remote assessment of dry eye symptoms","volume":"16","author":"Amparo","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/1756-0500-7-420","article-title":"Dry eye in LASIK patients","volume":"7","author":"Azuma","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jtos.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12886-015-0058-3","article-title":"The course of dry eye after phacoemulsification surgery","volume":"15","author":"Cetinkaya","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3341\/kjo.2009.23.2.65","article-title":"Dry eye after cataract surgery and associated intraoperative risk factors","volume":"23","author":"Cho","year":"2009","journal-title":"Kor J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jtos.2019.03.009","article-title":"Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes","volume":"17","author":"Fernandez","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib15","first-page":"589875","article-title":"The dry eye disease activity log study","author":"Iyer","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.jtos.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2018.03.039","article-title":"Effects of prolonged reading on dry eye","volume":"125","author":"Karakus","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/ICO.0000000000002045","article-title":"Short-term effects of ground-level ozone in patients with dry eye disease: a prospective clinical study","volume":"38","author":"Kim","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2015.10.011","article-title":"Long-term natural history of dry eye disease from the patient's perspective","volume":"123","author":"Lienert","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajo.2014.01.001","article-title":"Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions","volume":"157","author":"L\u00f3pez-Miguel","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/OPTH.S44688","article-title":"Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled phase 2 clinical trial in patients with dry eye","volume":"7","author":"Meerovitch","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib21","article-title":"Observation of influence of cataract surgery on the ocular surface","volume":"11","author":"Park","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.07.001_bib22","first-page":"633","article-title":"Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial","volume":"5","author":"Patane","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib23","article-title":"Symptom improvement in dry eye subjects following intranasal tear neurostimulation: results of two studies utilizing a controlled adverse environment [published online September 19, 2019]","author":"Pattar","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12325-015-0274-5","article-title":"SkQ1 ophthalmic solution for dry eye treatment: results of a phase 2 safety and efficacy clinical study in the environment and during challenge in the controlled adverse environment model","volume":"33","author":"Petrov","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.jtos.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajo.2011.11.003","article-title":"A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye","volume":"153","author":"Semba","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib26","first-page":"877","article-title":"Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, phase II clinical trial conducted using the controlled adverse environment (CAE\u2122) model","volume":"9","author":"Sosne","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/OPTH.S189039","article-title":"A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease","volume":"13","author":"Taylor","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1167\/iovs.12-11361","article-title":"Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease","volume":"54","author":"Teson","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/02713683.2012.757323","article-title":"Effectiveness of dry eye therapy under conditions of environmental stress","volume":"38","author":"Tomlinson","year":"2013","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3928\/1081597X-20140711-09","article-title":"Topical cyclosporine A treatment in corneal refractive surgery and patients with dry eye","volume":"30","author":"Torricelli","year":"2014","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jtos.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1111\/j.1755-3768.2010.01978.x","article-title":"Cytokine and chemokine levels in tears from healthy subjects","volume":"88","author":"Carreno","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The matrix metalloproteinase 9 point-of-care test in dry eye","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"573681","DOI":"10.1155\/2015\/573681","article-title":"Vascular endothelial growth factor in tear samples of patients with systemic sclerosis","author":"Rentka","year":"2015","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jtos.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40123-017-0110-x","article-title":"Use of the controlled adverse environment (CAE) in clinical research: a review","volume":"6","author":"Ousler","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1542-0124(12)70196-9","article-title":"Methodologies for the study of ocular surface disease","volume":"3","author":"Ousler","year":"2005","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ICO.0b013e31826671ab","article-title":"The effect of low humidity on the human tear film","volume":"32","author":"Abusharha","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/ICO.0b013e31812f67ca","article-title":"Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery","volume":"26","author":"Li","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.07.001_bib40","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archopht.120.8.1024","article-title":"Laser-assisted in situ keratomileusis for patients with dry eye","volume":"120","author":"Toda","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.07.001_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jcrs.2019.03.023","article-title":"An algorithm for the preoperative diagnosis and treatment of ocular surface disorders","volume":"45","author":"Starr","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jtos.2021.07.001_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3928\/1081597X-20080401-14","article-title":"LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment","volume":"24","author":"Ambr\u00f3sio","year":"2008","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jtos.2021.07.001_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2021.07.001_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/MNM.S107246","article-title":"Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome","volume":"4","author":"Pflugfelder","year":"2017","journal-title":"Metalloproteinases Med"},{"key":"10.1016\/j.jtos.2021.07.001_bib46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2147\/OPTH.S300047","article-title":"Short-term therapeutic effects of topical corticosteroids on refractory dry eye disease: clinical usefulness of matrix metalloproteinase 9 testing as a response prediction marker","volume":"15","author":"Ryu","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.07.001_bib48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaip.2017.05.001","article-title":"Asthma exacerbations: pathogenesis, prevention, and treatment","volume":"5","author":"Castillo","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jtos.2021.07.001_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00005-015-0345-y","article-title":"Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9","volume":"64","author":"Grzela","year":"2016","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.jtos.2021.07.001_bib50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1183\/09031936.06.00048605","article-title":"Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma","volume":"27","author":"Horvath","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtos.2021.07.001_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/1817-1737.140120","article-title":"Corticosteroids in the treatment of acute asthma","volume":"9","author":"Alangari","year":"2014","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.jtos.2021.07.001_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1183\/09031936.00119907","article-title":"The role of inhaled corticosteroids in the management of acute asthma","volume":"30","author":"Rowe","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtos.2021.07.001_bib53","first-page":"403042","article-title":"Gender and ocular manifestations of connective tissue diseases and systemic vasculitides","author":"Choudhary","year":"2014","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.07.001_bib54","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.15-16555","article-title":"Correlation between the inflammatory marker HLA-DR and signs and symptoms in moderate to severe dry eye disease","volume":"58","author":"Brignole-Baudouin","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.07.001_bib55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"Update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2021.07.001_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-020-00263-9","article-title":"Ocular surface pain: a narrative review","volume":"9","author":"Mehra","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2021.07.001_bib57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40135-017-0152-1","article-title":"Diagnosis and treatment of ocular pain: the ophthalmologist's perspective","volume":"5","author":"Jacobs","year":"2017","journal-title":"Curr Ophthalmol Rep"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:43:52Z","timestamp":1761540232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S1542012421000744"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.07.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry eye disease flares: A rapid evidence assessment","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}